The association of serum Kallikrein-8 with cognitive function in vascular dementia.

Abstract

Kallikrein-8 (KLK8) is a secreted serine protease related to learning and memory. Evidence has confirmed the important role of KLK8 in neuroplasticity. However, the role of KLK8 in vascular dementia (VaD) is unclear. The study recruited 88 VaD patients and 72 normal controls. All subjects were tested for cognitive function by Mini-Mental State Examination (MMSE) upon admission, and their demographic and biochemical data were collected. A sandwich Enzyme-Linked Immunosorbent Assay (ELISA) test was used to detect serum KLK8 levels. The demographic and biochemical data of the two groups of subjects were compared. Spearman's correlation and multivariate regression analysis were used to determine whether serum KLK8 in VaD patients is a risk factor for cognitive function. A total of 88 VaD patients and 72 controls with normal cognitive function were recruited and divided into VaD group and control group. Except for TT3 (p=0.002), there was no statistically significant difference in other demographic and biochemical data between the two groups (p>0.05). The results of ELISA indicated that the serum KLK8 in VaD patients was significantly higher than that of the control population (p<0.001). Spearman correlation analysis indicated that the serum KLK8 in VaD was significantly inversely correlated with the MMSE score. The results of Spearman's correlation analysis showed that the serum KLK8 level of VaD was significantly inversely correlated with the MMSE (r=-0.305, p=0.017). After correcting for interference factors, the correlation between the two is still significant (β=0.398, p=0.024). Serum KLK8 may be an independent risk factor affecting the cognitive function of VaD, which is worthy of further research.